Quick Comparison

Argireline (Acetyl Hexapeptide-3)Hyaluronic Acid
Typical ConcentrationTypically used at 5-10% concentration. Apply twice daily to expression line areas (forehead, around eyes, between brows). Effects visible after 2-4 weeks. Must be used continuously — effects reverse when stopped.Concentrations: 0.1-2%. Higher is not always better — concentrations above 2% can feel sticky and may actually pull moisture FROM skin in dry climates. Multi-molecular weight formulations are preferred. Apply to damp skin and seal with moisturizer.
ApplicationTopical (serum, cream). Water-soluble. Apply directly to expression line areas.Topical (serum, cream, mask). Apply to damp skin and layer occlusive on top. Injectable HA fillers are a separate medical category.
Research Papers10 papers10 papers
Categories

Mechanism of Action

Argireline (Acetyl Hexapeptide-3)

Argireline (acetyl hexapeptide-3) mimics the C-terminal region of SNAP-25, a core SNARE complex component. The SNARE complex (SNAP-25, syntaxin, synaptobrevin) mediates vesicle fusion at the neuromuscular junction for acetylcholine release. Argireline competes with SNAP-25 for syntaxin binding, partially disrupting SNARE assembly and reducing neurotransmitter exocytosis. This decreases acetylcholine release and attenuates facial muscle contraction intensity. The effect is dose-dependent, localized, and reversible—unlike botulinum toxin's enzymatic cleavage of SNAP-25. Clinical studies show ~30% wrinkle reduction versus 80%+ with injectable neurotoxins. Provides non-invasive expression line softening.

Hyaluronic Acid

Hyaluronic acid is a glycosaminoglycan (GAG) composed of repeating D-glucuronic acid and N-acetyl-D-glucosamine disaccharides. Its hydroxyl and carboxyl groups create strong hydrogen bonding with water—each molecule binds up to 1000x its weight in water. High molecular weight HA (>1000 kDa) forms a viscoelastic film on the stratum corneum, reducing transepidermal water loss (TEWL). Medium weight (100-1000 kDa) penetrates the upper epidermis. Low molecular weight HA (<100 kDa) reaches the dermis and binds CD44 and RHAMM receptors on fibroblasts, triggering ERK and PI3K signaling that stimulates fibroblast proliferation, hyaluronan synthase (HAS2) expression, and collagen I/III synthesis. Sodium hyaluronate—the salt form—has improved stability and penetration. Multi-weight formulations provide surface hydration and deeper dermal stimulation.

Risks & Safety

Argireline (Acetyl Hexapeptide-3)

Common

Very well-tolerated. Occasional mild tingling.

Serious

None documented.

Rare

Allergic reaction. At very high concentrations, some users report a slight 'droopy' feeling in the treated area.

Hyaluronic Acid

Common

Stickiness at high concentrations. In very dry/arid climates, HA can draw moisture from deeper skin layers to the surface where it evaporates.

Serious

None.

Rare

Mild irritation from very low molecular weight HA penetrating too deeply.

Full Profiles